Alexander Azoy Insider Trading $SNNA Sienna Biopharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alexander Azoy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alexander Azoy. Alexander Azoy is See Remarks in Unity Biotechnology, Inc. ($UBX) and Chief Financial Officer in Sienna Biopharmaceuticals, Inc. ($SNNA).
Alexander Azoy in Sienna Biopharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Alexander Azoy: Chief Financial Officer
Holdings: 103,552 shares
Latest Transaction: Oct 04 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Alexander Azoy in Sienna Biopharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 04 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Payment of Exercise | F | 0.23 | 2,396 | 551 | 103,552 | 105.9 K to 103.6 K (-2.26 %) |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | A | 0.71 | 20,000 | 14,200 | 20,000 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | A | 0.71 | 8,750 | 6,213 | 8,750 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | A | 0.71 | 8,750 | 6,213 | 8,750 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | A | 0.71 | 5,600 | 3,976 | 5,600 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | A | 0.71 | 25,000 | 17,750 | 25,000 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | D | 2.32 | 8,750 | 20,300 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | D | 2.32 | 8,750 | 20,300 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | D | 2.37 | 20,000 | 47,400 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | D | 15.08 | 5,600 | 84,448 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | D | 20.19 | 25,000 | 504,750 | 0 | |
| Aug 08 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Grant | A | 0.00 | 70,000 | 0 | 105,948 | 35.9 K to 105.9 K (+194.73 %) |
| Jul 03 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Payment of Exercise | F | 0.76 | 1,552 | 1,180 | 35,948 | 37.5 K to 35.9 K (-4.14 %) |
| Apr 03 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Option Exercise | A | 2.37 | 20,000 | 47,400 | 20,000 | |
| Apr 03 2019 | SNNA | Sienna Biopharmace ... | Azoy Alexander | Chief Financial Off ... | Grant | A | 0.00 | 20,000 | 0 | 37,500 | 17.5 K to 37.5 K (+114.29 %) |
Page: 1